Federal, State Governments Decline to Intervene in Qui Tam Lawsuit Targeting Allergan's Glaucoma Drug

NEW YORK — The federal government and state regulators have declined to intervene in a False Claims Act lawsuit accusing Allergan of marketing Lumigan without sufficient warnings that the glaucoma drug can cause sunken eyes.

The unsealing order was filed on Oct. 1 by the United States government, 29 states, and the District of Columbia in the U.S. District Court for the Southern District of New York.

Relator Jane Doe alleged in the 2014 complaint that Allergan, through human and animal studies, and medical journal articles, has long been aware that Lumigan can cause irreversible deepening of the upper eye …